Skip to content
Search

Latest Stories

Scottish community pharmacies global sum remuneration increased by 6 per cent to £220 million for 2023-24

Following discussions with Community Pharmacy Scotland, the Scottish government has agreed to a six per cent rise in the global fund allocation for community pharmacies in 2023-24, bringing the total remuneration to approximately £219.5 million.

A finalised agreement has been reached with Community Pharmacy Scotland for a one-year funding package for the financial year 2023-24, as stated in a Scottish government circular distributed to community pharmacy contractors and NHS Boards on August 4.


The circular said this settlement will lead to the most substantial increment ever approved for the community pharmacy network.

“The global sum remuneration will be £219.533 million, signifying a 6 per cent increase from the previous year and setting the groundwork for 2024/25," stated Professor Alison Strath, Chief Pharmaceutical Officer for Scotland, in the document. "The guaranteed income from the drug tariff will remain at £80 million for the financial year, without yearly changes."

However, the current level of guaranteed minimum income has increased by £15.95 million (19 per cent) to £100 million. “The delivery of the guaranteed minimum income will be closely monitored monthly throughout the year and further action to support contractor cashflow will be considered if appropriate,” Strath added.

As per the circular, details about margin sharing arrangements will be furnished in the upcoming weeks, guided by findings from the Scottish Government's community pharmacy regular pricing inquiry report.

According to the document, community pharmacy contractors will receive a one-off payment from an agreed fund of £1.66 million. "Payment will be calculated based on the activity in the April dispensing pool. This payment will adhere to a schedule where it's processed in June but will be distributed or paid out in August. This acknowledges the absence of a drug tariff adjustment for April 2023."

Community Pharmacy Scotland described the agreement as mutually beneficial, offering a more stable financial perspective for pharmacies following a demanding 2022-23 characterised by financial, workforce, and workload pressures. "This guaranteed minimum income comes from the reimbursement aspect of our financial structure. It represents the lowest amount we consider acceptable this year from the Tariff, designed to aid the expenses of service provision throughout our financial framework,” said CPS.

"We are currently working with Scottish government to fine-tune the details of how we would handle underperformance, aiming for this to be a responsive measure to protect our cashflow,” CPS added.

The new funding agreement for 2023-24, involving over 1,200 community pharmacies, was initially announced on July 21. However, specific details weren't made public until two weeks later.

During his UCL School of Pharmacy Lecture in June, CPS CEO Professor Harry McQuillan urged UK pharmacists to prioritise 'safety of supply' over 'accuracy of supply' for patients. He emphasised investing in teams, technology, and embracing a more clinical future to ensure maximum benefits from prescribed medicines.

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less